$390,000 of EDWARDS LIFESCIENCES LLC lobbying was just disclosed, from Q4 of 2024, in a new Lobbying Disclosure Act filing.
This included lobbying on issues like:
"Implementation of PL 114-255, 21st Century Cures Act Ensuring Patient Access to Critical Breakthrough Products (H.R.1691/S.5439) Transitional Coverage for Emerging Technologies (TCET) guidance Policies promoting medical innovation Heart Valve Disease Awareness FDA Reauthorization for 2022/FDA User Fees Health Equity Issues (Diversity in Clinical Trials) H.R.6000 Cures 2.0 Act (includes CURES 2.1 proposal) Shortage Reporting Coverage with Evidence Development CMS Coverage Policies For Medical Devices Implementation of PL 114-255, 21st Century Cures Act CMS Payment Policies for Medical Devices Ensuring Patient Access to Critical Breakthrough Products (H.R.1691/S.5349) (includes MCIT/TCET) Heart Valve Disease Awareness National Coverage Determination for TAVR Coverage of Transcatheter Tricuspid Valve Replacement Health Equity Issues Coverage with Evidence Development Corporate Tax Reform Proposals Supply Chain Proposals"
You can find more data on corporate lobbying on Quiver Quantitative.
EW Congressional Stock Trading
Members of Congress have traded $EW stock 1 times in the past 6 months. Of those trades, 0 have been purchases and 1 have been sales.
Here’s a breakdown of recent trading of $EW stock by members of Congress over the last 6 months:
- SENATOR MARKWAYNE MULLIN sold up to $50,000 on 08/20.
To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.
EW Insider Trading Activity
EW insiders have traded $EW stock on the open market 13 times in the past 6 months. Of those trades, 0 have been purchases and 13 have been sales.
Here’s a breakdown of recent trading of $EW stock by insiders over the last 6 months:
- DONALD E JR BOBO (CVP,Strategy/Corp Development) has made 0 purchases and 6 sales selling 30,000 shares for an estimated $2,042,108.
- LARRY L WOOD (Global President TAVR & Surg) sold 25,000 shares for an estimated $1,647,862
- SCOTT B. ULLEM (CVP, Chief Financial Officer) sold 11,250 shares for an estimated $806,405
- DANIEL J. LIPPIS (CVP, JAPAC) has made 0 purchases and 2 sales selling 3,000 shares for an estimated $219,577.
- DAVEEN CHOPRA (CVP, TMTT) has made 0 purchases and 2 sales selling 3,000 shares for an estimated $215,660.
- WAYNE MARKOWITZ (GM & SVP, Surgical) sold 583 shares for an estimated $42,716
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
EW Hedge Fund Activity
We have seen 478 institutional investors add shares of EW stock to their portfolio, and 728 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- WELLINGTON MANAGEMENT GROUP LLP added 14,610,123 shares (+86.3%) to their portfolio in Q3 2024, for an estimated $964,122,016
- ALLIANCEBERNSTEIN L.P. removed 13,357,889 shares (-65.7%) from their portfolio in Q3 2024, for an estimated $881,487,095
- VANGUARD GROUP INC added 9,018,528 shares (+16.8%) to their portfolio in Q3 2024, for an estimated $595,132,662
- BROWN ADVISORY INC removed 8,972,491 shares (-54.2%) from their portfolio in Q3 2024, for an estimated $592,094,681
- NINETY ONE UK LTD added 6,895,970 shares (+1658.6%) to their portfolio in Q3 2024, for an estimated $455,065,060
- FMR LLC removed 5,773,245 shares (-75.7%) from their portfolio in Q3 2024, for an estimated $380,976,437
- WINSLOW CAPITAL MANAGEMENT, LLC removed 5,270,590 shares (-100.0%) from their portfolio in Q3 2024, for an estimated $347,806,234
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
